Journal of Nuclear Medicine: 53 (9)

September 1, 2012; Volume 53,Issue 9

Cover image

This image shows the lymphatics and the main nodal stations in a mouse after injection of ¹⁸F-FDG intracutaneously into the tail in a 3-dimensional PET/CT reconstruction.
See page 1438.

In this issue

Issue highlights

¹⁸F-FDG Uptake by Metastatic Axillary Lymph Nodes on Pretreatment PET/CT as a Prognostic Factor for Recurrence in Patients with Invasive Ductal Breast Cancer
Workflow and Scan Protocol Considerations for Integrated Whole-Body PET/MRI in Oncology
Positron Lymphography: Multimodal, High-Resolution, Dynamic Mapping and Resection of Lymph Nodes After Intradermal Injection of ¹⁸F-FDG

First-in-Human Assessment of ¹¹C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval of PSMA
Fibroblast Activation Protein–Targeted PET/CT with ⁶⁸Ga-FAPI for Imaging IgG4-Related Disease: Comparison to ¹⁸F-FDG PET/CT

More...

Main menu

User menu

Search

Table of Contents

Cover image

In this issue

Issue highlights

Jump to